Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, was responsible for 1.25 million deaths in 2023, 13% of which were among people living with HIV. Currently, the main ...

NBC News reported this week that President Donald Trump’s administration is thinking about getting rid of the Centers for Disease Control and Prevention’s division that focuses on HIV ...

The study was just one being conducted through the Adolescent Medicine Trials Network for HIV Interventions, which formed in 2001 to find ways to prevent HIV in children. It has received NIH ...

As of the end of 2023, nearly 40 million people worldwide were living with HIV, including approximately 1.2 million in the United States. In the same year, about 630,000 people globally died from ...

During his 2019 State of the Union address, President Donald Trump laid out an ambitious goal: end HIV in the United States by 2030. But six years later, his actions are actively undermining that ...

HIV doesn’t cause urinary symptoms on its own but may increase your risk of a health condition, such as a urinary tract infection or kidney damage, that can lead to symptoms. Living with HIV can ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term protection. If this yearly injection is approved and widely implemented ...

WASHINGTON, March 18 (Reuters) - The U.S. health department said on Tuesday it is reviewing the Centers for Disease Control and Prevention's HIV prevention division for overlap with other ...

Feb. 18, 2025 — Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication.

Trump once pledged to end HIV/AIDS in the U.S. by 2030. Now his administration is reportedly looking to slash funding for domestic HIV prevention programs ...

Why: The stock's decline follows a report from The Wall Street Journal that the US Health and Human Services Department is considering drastic cuts to federal funding for HIV prevention in the US.

When it came to innovations in biotech, there was a clear winner: lenacapavir, a drug that was found to prevent HIV infections in 100% of the women and girls who received it in a clinical trial.